International Medical Science Liaison Day

Imagine a bridge connecting the world of medicine with the realm of science. Medical Science Liaisons (MSLs) serve as this vital link.

They operate at the intersection of research, clinical care, and everyday practice, translating complex evidence into practical understanding while bringing real-world questions back to the people generating the data. When the story of a therapy is still unfolding, MSLs help keep the narrative clear, accurate, and centered on patient impact.

These professionals have advanced scientific training, often at the doctoral level. They focus on specific therapeutic areas such as oncology, cardiology, or neurology.

That depth of specialization is essential because modern medicine is highly complex and often very narrow in focus. An MSL may spend years developing expertise in one disease area, understanding its standard of care, following new studies as they appear, and learning how clinicians make decisions when evidence is incomplete or evolving.

While many MSLs hold PhDs, PharmDs, or MDs, the role is defined less by a specific degree and more by the ability to interpret data, communicate clearly, and earn the trust of highly knowledgeable experts.

Their main responsibility is building and maintaining peer-to-peer relationships with leading physicians, known as Key Opinion Leaders (KOLs), at major academic centers and clinics. Through these relationships, MSLs help ensure that medical products are used appropriately, acting as scientific peers and trusted resources within the healthcare community.

The peer-to-peer aspect is central to the role. MSLs must be comfortable discussing study design, endpoints, statistical interpretation, and safety signals without exaggeration or minimizing uncertainty. Many conversations focus less on a product and more on what the evidence truly shows.

This may involve explaining a therapy’s mechanism of action, reviewing pivotal clinical trial data, clarifying subgroup findings, or discussing how a safety profile was established.

In daily practice, MSL responsibilities often include:

Scientific exchange with clinicians and researchers: responding to data-driven questions, presenting balanced information, and helping experts interpret new evidence in context.
Gathering medical insights: identifying patterns in clinical experience, unmet needs, and treatment barriers, then sharing these insights internally to guide research and strategy.
Supporting research and education: connecting investigators with clinical trial opportunities or investigator-initiated research and identifying educational gaps where stronger disease understanding could improve care.
Congress and publication awareness: monitoring major medical meetings and peer-reviewed literature to keep organizations aligned with the latest scientific developments.

Because MSLs work closely with healthcare professionals, strong ethics and compliance practices are fundamental. In many organizations, MSLs function in a non-promotional role, meaning discussions must remain balanced, evidence-based, and free from commercial bias.

They are also trained to manage off-label questions appropriately, document specific interactions, and report safety information when necessary. In other words, they do not simply connect science and medicine. They do it responsibly.

This day recognizes the important role MSLs play throughout the lifecycle of healthcare products. Their work helps ensure therapies are understood and used appropriately.

Even before a treatment becomes widely adopted, MSLs may help interpret early data, identify which clinical questions matter most to specialists, and provide field insights that influence future studies.

As therapy enters broader use, the focus often shifts toward education, ongoing evidence review, and supporting scientific discussion around best practices.

Across the product lifecycle, MSLs frequently collaborate with a wide internal network, including medical affairs leadership, clinical development teams, regulatory experts, pharmacovigilance or drug safety groups, and sometimes market access or patient-focused teams.

The objective is not just awareness of a therapy, but accurate understanding, appropriate use, and continuous learning as the evidence evolves.

Their work contributes to improved patient outcomes and ongoing progress in medical science. Recognizing this day honors their dedication and the critical role they play in connecting scientific research with clinical care.

It also draws attention to a type of healthcare work that often remains invisible to patients. Many people never interact with an MSL, yet these professionals influence how quickly accurate information spreads, how carefully new data is interpreted, and how effectively the scientific community communicates about changing standards of care.

How to Celebrate International Medical Science Liaison Day

International Medical Science Liaison Day is a great opportunity to recognize professionals who connect science and medicine. Here are some meaningful ways to celebrate:

Give a Shout-Out

Public recognition can have a strong impact. Sharing a post about Medical Science Liaisons (MSLs) on social media or writing a short blog helps raise awareness.

A thoughtful shout-out goes beyond a simple thank-you. It can highlight what makes the role unique: evidence-based communication, ethical scientific dialogue, and the ability to translate complex information between research and clinical practice.

In workplaces, a short message on an internal platform can become an “MSL spotlight,” featuring a colleague’s therapeutic area, a recent project, or a strength such as simplifying complex trial data.

Adding a personal example makes appreciation more meaningful. This could be a moment when an MSL helped a clinician locate key evidence for a patient-care decision or when field insights contributed to a more patient-focused research direction. Specific recognition feels authentic.

Organize a Trivia Game

A friendly competition can make the celebration engaging. Hosting a quiz about MSLs, medical discoveries, or pharmaceutical innovation can be both educational and fun.

To keep it relevant, trivia topics might include:

Key clinical trial concepts (endpoint, randomization, confidence interval)
The meaning and importance of real-world evidence
How advisory boards function
The difference between a scientific poster and a peer-reviewed article
What a KOL is and why peer-to-peer exchange matters

Whether held in an office, classroom, or virtual setting, this activity encourages learning while highlighting the role. Teams that work with MSLs can also include a “Myth vs. Fact” round to address common misconceptions, such as the belief that MSLs are part of the sales function.

Surprise an MSL with Gratitude

A simple thank-you can be very meaningful. A handwritten note, a small gift, or even a coffee treat can show appreciation for work that often happens behind the scenes.

Recognition is most effective when it reflects the realities of the role. Many MSLs spend significant time preparing for complex scientific discussions, adjusting schedules to match clinician availability, and staying current in rapidly evolving therapeutic areas.

A note such as, “Thank you for helping our team stay evidence-focused and up to date,” acknowledges what the work truly involves.

Organizations can also show appreciation through practical support, such as protecting time for literature review, encouraging professional development, or reducing meetings to allow focused scientific work. Recognition is not only about praise. It is also about enabling effectiveness.

Explore the Science They Support

Taking time to learn about the research MSLs help communicate can deepen appreciation. Medical journals, podcasts, or documentaries are good starting points.

An accessible approach is to explore one therapeutic area at three levels:

Disease basics: what the condition is and how it affects patients’ lives.
Treatment landscape: common goals, options, and clinical trade-offs.
Current research: the types of studies shaping practice and the questions that remain open.

Understanding their scientific environment highlights the importance of their work. Within healthcare organizations, a group journal club can be especially fitting. Reviewing one relevant study and discussing its strengths, limitations, and real-world implications reflects the careful interpretation MSLs support every day.

Start a Conversation

Talking about the MSL role with colleagues, students, or friends helps increase awareness. Conversations about how they connect research with patient care make their contribution more visible.

A simple conversation starter is: “Who helps clinicians stay aligned with the latest evidence?” This opens the door to explaining how MSLs function as scientific partners and relationship-builders.

This is also an opportunity to highlight career paths in science beyond traditional laboratory roles. For students and early-career professionals, the MSL position demonstrates how scientific knowledge, communication skills, and curiosity can come together in a role that directly influences how medical knowledge moves through healthcare systems.

1967
Upjohn Introduces the First Field-Based Medical Science Liaisons
Upjohn Pharmaceuticals created a new role of medically trained field specialists to discuss complex data with physicians, widely cited as the birth of the medical science liaison profession.

[1]
1970s–1980s
MSLs Distinguished Scientific Exchange from Sales Promotion
As FDA scrutiny of drug promotion grew and therapies became more complex, companies increasingly relied on MSLs for peer‑level, non-promotional scientific discussions separate from traditional sales teams.

[1]
1999
PhRMA Code Helped Push Scientific Roles Out of Purely Commercial Space
The Pharmaceutical Research and Manufacturers of America (PhRMA) issued a voluntary code on interactions with healthcare professionals, contributing to a clearer separation between promotional sales activities and non-promotional medical roles such as MSLs.
Early 2000s
Biologics and Specialty Drugs Drive Expansion of MSL Teams
The rise of biologics and targeted therapies demands deeper disease‑area expertise, leading many pharmaceutical and biotech companies to grow their Medical Science Liaison groups across multiple therapeutic areas.

[1]
2009
Regulatory Guidance Begins Explicitly Addressing MSL Activities
Industry and compliance experts note that by 2009, a series of corporate integrity agreements and regulatory documents started to directly or indirectly define appropriate duties and limits for Medical Science Liaison professionals.

[1]
2011
Comprehensive Guide Codifies the Modern MSL Function
Publication of “The Medical Science Liaison: An A to Z Guide” helps formalize expectations for MSL responsibilities, emphasizing scientific exchange, KOL relationship building, and support of clinical research as core parts of the role.

[1]
2021
International Position Paper Proposes Best Practices for MSLs
An expert group publishes a peer‑reviewed position paper in Therapeutic Innovation & Regulatory Science outlining best practices for Medical Science Liaisons, including competencies, metrics, and ethical standards for scientific engagement.

[1]

History of International Medical Science Liaison Day

International Medical Science Liaison (MSL) Day honors professionals who connect pharmaceutical companies with healthcare experts. The role began in 1967 when Upjohn Pharmaceuticals introduced it to bridge the gap between research and clinical practice.

The late 1960s were marked by rapid scientific progress and increasing therapeutic complexity. As medical data expanded and treatment decisions became more specialized, the need grew for scientifically trained professionals who could discuss evidence credibly with clinicians.

Creating a dedicated role for scientific engagement helped establish structured, two-way communication between therapy developers and those using treatments in practice.

Over time, the position evolved from a new concept into a well-recognized profession. MSLs became part of medical affairs organizations, with a strong focus on scientific accuracy, responsible communication, and long-term relationships with clinical experts.

As fields such as oncology and neurology advanced, demand increased for professionals who could keep pace with fast-changing evidence and translate it into meaningful clinical discussion.

Recognizing the profession’s growing importance, the Medical Science Liaison Society (MSL Society) established International MSL Day. March 27 was chosen to mark the date the MSL Society became a nonprofit organization.

Creating a dedicated day also reflects the professionalization of the field. Many organizations now define clear competencies, expectations, and ethical boundaries for MSLs. Ongoing discussions around training standards, best practices, and professional development emphasize protecting the integrity of scientific exchange and keeping patient benefit at the center.

The first official celebration took place in 2020, marking a milestone for the profession. Since then, the day has gained global recognition, highlighting the essential role MSLs play in advancing medical science.

This recognition matters because the role is often misunderstood. The term “liaison” can seem vague until the work is seen firsthand: detailed data analysis, preparation for expert-level discussions, careful collection of clinical insights, and translating those insights into actions that improve research, education, and scientific communication. The day helps bring visibility to that effort.

Each year, organizations host activities that raise awareness and appreciation for MSL contributions. These events strengthen professional connections across therapeutic areas and support a shared commitment to scientific excellence.

Celebrations often include professional recognition, team spotlights, educational sessions, and opportunities for community building. For teams that collaborate with MSLs, the day is also a reminder to involve them early in scientific discussions, seek their perspective on evidence interpretation, and value their ability to bring the clinician voice into strategic decisions.

International MSL Day ultimately celebrates the expertise and dedication MSLs bring to healthcare. Their work supports clear, responsible communication between organizations and healthcare professionals, helping ensure that patients benefit from accurate understanding and evidence-based care.

At its best, the role reflects how modern healthcare truly advances: not through isolated discoveries alone, but through ongoing, thoughtful dialogue between research and clinical practice. MSLs help keep that dialogue accurate, meaningful, and grounded in science, making their work well worth recognizing.

The Evolution and Expanding Impact of Medical Science Liaisons

Medical Science Liaisons (MSLs) have transformed from a specialized support role into a strategic force at the heart of modern healthcare and pharmaceutical innovation.

These facts highlight how the role emerged, why it grew in importance, and how MSLs now contribute across the entire drug lifecycle to ensure scientific accuracy, compliance, and better patient outcomes.

MSLs Emerged as a Response to Increasingly Complex Medicine
The Medical Science Liaison role was created in 1967 at Upjohn Pharmaceuticals after the company realized that traditional sales representatives could no longer adequately answer physicians’ increasingly complex scientific questions about new therapies.
Upjohn’s solution was to deploy field-based staff with advanced scientific or clinical training who could hold peer-level discussions with specialists and support evidence-based use of medicines.
Regulatory Crackdowns Helped Fuel the Growth of MSL Teams
In the late 1990s and early 2000s, new industry codes and U.S. Office of Inspector General guidance tightened rules on promotional interactions between pharmaceutical sales representatives and healthcare professionals.
As companies reduced or reshaped their sales forces, many shifted scientific discussions to Medical Science Liaisons, whose non-promotional remit and focus on fair and balanced information fit better within emerging compliance expectations.
MSLs Are Now Involved Across the Entire Drug Lifecycle
Originally focused on supporting marketed products, MSLs today commonly contribute from early clinical development through loss of exclusivity.
Industry analyses describe MSLs helping identify trial sites and investigators, gathering real-world insights during development, supporting launch education, and later generating real-world evidence and health economics data, reflecting a shift from “scientific support” to strategic partnership in medical affairs.
Field-Based Scientific Exchange Can Change Clinical Practice
A multi-country “SMART MSL” study published in an MSL-focused journal found that after MSL-led education on specific therapies, 95% of participating healthcare professionals reported increased awareness of treatment strategies, and 70% said they intended to change their clinical practice.
Most participants also rated the education as highly relevant to their patients, suggesting that high-quality scientific exchange can directly influence care decisions.
Professional Guidelines Now Define Best Practices for MSL Conduct
Given their unique position between industry and clinicians, Medical Science Liaisons are increasingly guided by formal best-practice recommendations.
A 2021 position paper in a peer-reviewed journal outlined standards for MSL activities, emphasizing that scientific exchange should be non-promotional, evidence-based, and clearly separated from commercial objectives, with careful documentation and compliance training to safeguard scientific integrity and patient interests.
MSL Value Is Shifting From Activity Counts to Patient-Focused Outcomes
Historically, companies often measured MSL performance using simple activity metrics such as the number of visits or slides presented.
Recent medical affairs literature argues for a shift toward patient-centered indicators, such as how MSL insights influence clinical guidelines, support better trial recruitment, or help close evidence gaps that affect patient outcomes, reflecting a broader redefinition of what “value” means in this profession.
Medical Affairs Is Emerging as a “Third Pillar” of Pharma
Consulting and industry analyses increasingly describe medical affairs, which includes MSLs, as a “third strategic pillar” of biopharmaceutical companies alongside research and commercial functions.
By 2030, medical affairs is expected to play a central role in shaping evidence generation, ensuring that real-world data, patient perspectives, and clinician insights guide development and market access decisions, with MSLs acting as a key interface to the healthcare system.

International Medical Science Liaison Day FAQs

What does a Medical Science Liaison actually do in everyday practice?

A Medical Science Liaison (MSL) is a field‑based scientific expert who builds peer‑to‑peer relationships with leading healthcare professionals and researchers.

In daily work, MSLs visit hospitals and academic centers, discuss published and emerging data, explain mechanisms of action and clinical trial results, support investigator‑initiated studies, attend scientific congresses, and relay medical insights back to their company’s medical and research teams.

Their activities are non‑promotional and centered on scientific exchange rather than sales targets. [1]

How is an MSL role different from a pharmaceutical sales representative?

MSLs typically sit within Medical Affairs and focus on unbiased scientific exchange, while sales representatives work in Commercial or Sales and focus on promoting approved products.

MSLs usually hold doctorate‑level degrees and engage in long, in‑depth discussions with key opinion leaders about disease biology, trial design, and complex data, including appropriate handling of off‑label questions under strict compliance rules.

Sales representatives generally have shorter visits with a broader group of prescribers, must stay strictly on‑label, and are measured primarily on sales and call‑volume metrics. [1]

What education and experience are usually required to become a Medical Science Liaison?

Most MSLs hold an advanced degree, such as an MD, PharmD, or PhD in a life science, which allows them to speak as scientific peers with specialist physicians and researchers.

Employers also strongly value prior clinical practice, postdoctoral or industry research, experience with clinical trials, and a track record of presenting or publishing scientific work.

In addition, the Medical Science Liaison Society’s board certification requires at least one year of full‑time experience as an MSL or MSL manager, reflecting the expectation of substantial domain expertise. [1]

How do Medical Science Liaisons contribute to evidence‑based medicine and real‑world evidence?

MSLs help clinicians interpret complex clinical trial data, guidelines, and safety information so that treatment decisions rest on the best available evidence.

They also support real‑world evidence generation by identifying research questions from clinical practice, advising on study design, and facilitating appropriate observational or investigator‑initiated studies.

Insights gathered from the field about effectiveness, tolerability, and unmet needs are fed back to Medical Affairs and R&D, which can influence label updates, risk management plans, and future trials. [1]

What ethical and compliance standards govern the work of Medical Science Liaisons?

MSLs operate under strict ethical and regulatory frameworks intended to separate scientific exchange from product promotion.

Best‑practice guidelines emphasize that MSLs must not be measured on sales, must avoid joint promotional calls with sales representatives except for limited introductions, and must respond to off‑label questions only in a reactive, balanced, and well‑documented way.

Companies are expected to ensure clear reporting lines into Medical Affairs and provide training on regulations such as FDA and EMA rules, local advertising codes, and internal codes of conduct.

Are Medical Science Liaison roles the same worldwide, or do they differ by region?

The core purpose of MSLs as scientific liaisons is broadly similar worldwide, but healthcare systems and regulations shape how the role looks in practice.

In highly regulated markets like the United States and the European Union, there is a strong structural separation between Medical Affairs and Commercial, detailed rules around off‑label discussions, and clear expectations that MSLs remain non‑promotional.

Position papers from European experts describe MSLs as the “scientific face” of industry and recommend global best practices, yet note that titles, reporting lines, and the balance of responsibilities can differ across countries and companies. [1]

What are common misconceptions about Medical Science Liaisons?

One frequent misconception is that MSLs are simply senior sales representatives or “product advocates,” when in fact their primary responsibility is independent scientific exchange, not selling.

Another misconception is that every job in Medical Affairs is an MSL role, even though Medical Affairs also includes medical directors, safety experts, and other functions.

These misunderstandings can blur the line between promotion and science and are a key reason why professional groups stress that MSLs should be clearly separated from sales structures and evaluated on scientific, not commercial, outcomes. [1]